发明名称 Positive controls for expression modulating experiments
摘要 The invention pertains to the use of an apoptosis inducing combination of at least a. a first expression modulating compound silencing the expression of a first target gene involved in apoptosis and b. a second expression modulating compound silencing the expression of a second target gene involved in apoptosis as a positive control in expression modulating assays.
申请公布号 EP2075333(A1) 申请公布日期 2009.07.01
申请号 EP20070025198 申请日期 2007.12.28
申请人 QIAGEN GMBH 发明人 HAHN, PETER, DR.;DENNIG, JOERG, DR.;BIELKE, WOLFGANG, DR.;KANG, JIE, DR.
分类号 A61K31/713;C12N15/11;C12N15/113;C12Q1/68 主分类号 A61K31/713
代理机构 代理人
主权项
地址